Chitosan immunomodulatory properties: perspectives on the impact of structural properties and dosage

David Fong1 & Caroline D Hoemann*,1,2,3 1Institute of Biomedical Engineering, École Polytechnique, Montreal, QC, H3T 1J4, Canada 2Department of Chemical Engineering, École Polytechnique, Montreal, QC, H3T 1J4, Canada 3Bioengineering Department, George Mason University, Institute for Advanced Biomedical Research, Manassas, VA 20110, USA * Author for correspondence: Tel.: +1 703 993 5884; Fax: +1 703 993 2077; choemann@gmu.edu

[1]  A. Cheng,et al.  Lysosomal rupture induced by structurally distinct chitosans either promotes a type 1 IFN response or activates the inflammasome in macrophages. , 2017, Biomaterials.

[2]  C. Hoemann,et al.  Immunological responses to chitosan for biomedical applications , 2017 .

[3]  A. Bowie,et al.  The Vaccine Adjuvant Chitosan Promotes Cellular Immunity via DNA Sensor cGAS-STING-Dependent Induction of Type I Interferons. , 2016, Immunity.

[4]  P. Petersen,et al.  Chitosan leads to downregulation of YKL-40 and inflammasome activation in human macrophages. , 2015, Journal of biomedical materials research. Part A.

[5]  A. Sher,et al.  Type I interferons in infectious disease , 2015, Nature Reviews Immunology.

[6]  C. Hoemann,et al.  Biodegradable chitosan microparticles induce delayed STAT-1 activation and lead to distinct cytokine responses in differentially polarized human macrophages in vitro. , 2015, Acta biomaterialia.

[7]  Jennifer P. Wang,et al.  Spectrum and Mechanisms of Inflammasome Activation by Chitosan , 2014, The Journal of Immunology.

[8]  M. Barbosa,et al.  Macrophage polarization following chitosan implantation. , 2013, Biomaterials.

[9]  M. Shive,et al.  Novel scaffold-based BST-CarGel treatment results in superior cartilage repair compared with microfracture in a randomized controlled trial. , 2013, The Journal of bone and joint surgery. American volume.

[10]  Michael D. Buschmann,et al.  Chitosans for delivery of nucleic acids , 2013, Advanced Drug Delivery Reviews.

[11]  M. Jolicoeur,et al.  Chitosan Rate of Uptake in HEK293 Cells is Influenced by Soluble versus Microparticle State and Enhanced by Serum-Induced Cell Metabolism and Lactate-Based Media Acidification , 2013, Molecules.

[12]  Manmohan J. Singh,et al.  The vaccine adjuvant alum inhibits IL‐12 by promoting PI3 kinase signaling while chitosan does not inhibit IL‐12 and enhances Th1 and Th17 responses , 2012, European journal of immunology.

[13]  Christopher H. Taron,et al.  Chitosan but Not Chitin Activates the Inflammasome by a Mechanism Dependent upon Phagocytosis* , 2011, The Journal of Biological Chemistry.

[14]  I. Hammami,et al.  Biodegradable chitosan particles induce chemokine release and negligible arginase-1 activity compared to IL-4 in murine bone marrow-derived macrophages. , 2011, Biochemical and biophysical research communications.

[15]  M. Buschmann,et al.  High efficiency gene transfer using chitosan/DNA nanoparticles with specific combinations of molecular weight and degree of deacetylation. , 2006, Biomaterials.

[16]  M. Shive,et al.  Chitosan-glycerol phosphate/blood implants improve hyaline cartilage repair in ovine microfracture defects. , 2005, The Journal of bone and joint surgery. American volume.

[17]  O. Smidsrod,et al.  Preparation and characterisation of oligosaccharides produced by nitrous acid depolymerisation of chitosans. , 2001, Carbohydrate research.

[18]  J. Desbrières,et al.  Influence of acetic acid concentration on the solubilization of chitosan , 1999 .

[19]  O. Smidsrod,et al.  Determination of the degree of N-acetylation and the distribution of N-acetyl groups in partially N-deacetylated chitins (chitosans) by high-field n.m.r. spectroscopy. , 1991, Carbohydrate research.

[20]  I Saiki,et al.  Immunological activity of chitin and its derivatives. , 1984, Vaccine.